Aspen Clinical Research is currently enrolling qualified applicants into a clinical research study for those who have been diagnosed with Multiple Sclerosis. Participants in this study will receive an IV investigational medication as an add-on therapy to current Anti-Inflammatory Disease-Modifying Therapies. The primary objective of this study is to evaluate the effects of the investigational medication in decreasing symptoms of multiple sclerosis.
Your first visit to the research clinic will be a screening visit. During this visit you will meet with a study coordinator to fully review study details. If you decide to participate, a more in depth assessment of your health will take place to determine your final eligibility. If you are eligible and choose to enroll, you will be required to return to our research clinic various times for treatment and follow-up visits.
Space in the study is limited. Health insurance is not required. All clinical visits, medications, and physical exams are provided at no cost to you. Those who qualify and participate in this clinical research study may receive reimbursement for time and travel.
Please complete the information below to see if you pre-qualify for the study.
Disclaimer: Not all individuals that complete the on-line questionnaire will qualify for the study. An in-depth study and medical evaluation must be completed in person in order to qualify for the study.